Press Releases
Filter by
Frontier Medicines Presents Preclinical Data from Three Programs at the 37th AACR-NCI-EORTC International Conference on Molecular Targets
October 22, 2025
Frontier Medicines Presents Preclinical Data from Three Programs at the 37th AACR-NCI-EORTC International Conference on Molecular Targets
October 22, 2025
Frontier Medicines Unveils New Preclinical Data for FMC-220, a First-in-Class Covalent p53 Y220C Activator, at AACR 2025
April 28, 2025
Frontier Medicines Announces FMC-220, the First Covalent p53 Y220C Activator Development Candidate, with Best-in-Class Potential
January 9, 2025
Frontier Medicines Appoints Gerardo Ubaghs as Chief Financial Officer and Announces $20 Million Series C Extension
June 25, 2024
Frontier Medicines to Present Preclinical Data at the American Association for Cancer Research Annual Meeting 2024
March 21, 2024
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline
February 22, 2024
Frontier Medicines Announces Appointment of Andrew Krivoshik, M.D., Ph.D., as Chief Medical Officer
May 8, 2023
Frontier Medicines Expands Leadership Team with Addition of Christo Shalish as Head of Business Development
February 28, 2023
Frontier Medicines Announces Advancement of Second and Third Programs Under Global Partnership with AbbVie
January 5, 2023
Frontier Medicines Announces Appointment of Accomplished Finance and Operations Executive, Setareh “SiSi” Pouraghabagher, to Board of Directors
November 8, 2022
Frontier Medicines Announces the Appointment of Seasoned Legal Executive Mark Dizon, J.D., as General Counsel
August 25, 2022
Frontier Medicines Announces Distinguished Oncologist Dr. Pasi Jänne Joins its Scientific Advisory Board
July 14, 2022
Frontier Medicines Announces Prominent Oncologist Dr. Scott Kopetz Joins its Scientific Advisory Board
June 21, 2022
Frontier Medicines Announces the Appointment of Monique Bobadilla as Chief People and Culture Officer
March 8, 2022
Frontier Medicines Announces Renowned Physician Scientist Piro Lito, M.D., Ph.D., Joins Scientific Advisory Board
February 8, 2022
Frontier Medicines Announces Advancement of First Program Under Global Partnership with AbbVie
January 10, 2022
Frontier Medicines to Present at the RBC Capital Markets Healthcare Private Company Virtual Conference
December 9, 2021
Frontier Medicines Announces the Appointment of Marguerite Hutchinson, J.D., as Chief Business Officer
November 17, 2021
Frontier Medicines to Present at the Cantor Global Healthcare Conference
September 23, 2021
Frontier Medicines Appoints Seasoned Executive Gregory Chow as Chief Financial Officer
March 31, 2021
Frontier Medicines Appoints Drug Development Expert David M. Goldstein, Ph.D., to its Board of Directors
March 30, 2021
Chemical & Engineering News Names Frontier Medicines One of Its 10 Chemistry Start-Ups to Watch
November 11, 2019
FierceBiotech Names Frontier Medicines One of Its “Fierce 15” Biotech Companies of 2019
September 23, 2019